![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
In vitro studies investigating the mechanism of interaction between TMC435 and hepatic transporters
|
|
|
Reported by Jules Levin
AASLD Nov 2 Boston
M. T. Huisman,1 J. Snoeys,1 J. Monbaliu,1 M. Martens,2 V. Sekar,3 A. Raoof4
1Janssen Pharmaceutical Companies of Johnson & Johnson, Research and Development, Beerse, Belgium; 2Formerly Tibotec, Beerse, Belgium; 3Tibotec Inc., Titusville, NJ, USA; 4Tibotec, Beerse, Belgium
Disclosure: MTH, JS, and JM are employees of Janssen Pharmaceutical Companies of Johnson & Johnson. VS and AR are employees of Tibotec.
![](../images/112110/112110-15/image002.gif)
![](../images/112110/112110-15/image004.gif)
![](../images/112110/112110-15/image006.gif)
![](../images/112110/112110-15/image008.gif)
![](../images/112110/112110-15/image010.gif)
![](../images/112110/112110-15/image012.gif)
![](../images/112110/112110-15/image014.gif)
![](../images/112110/112110-15/image016.gif)
![](../images/112110/112110-15/image018.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|